These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27586003)

  • 1. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia.
    Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Bourgeat P; Martins RN; Salvado O; Rowe CC; Masters CL; Maruff P;
    J Mol Neurosci; 2016 Nov; 60(3):362-370. PubMed ID: 27586003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
    Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
    Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
    Lim YY; Ellis KA; Harrington K; Pietrzak RH; Gale J; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P
    J Alzheimers Dis; 2013; 33(4):1167-76. PubMed ID: 23160011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
    Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
    JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
    Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
    J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
    Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
    J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
    Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.
    Hanseeuw B; Dricot L; Lhommel R; Quenon L; Ivanoiu A
    J Alzheimers Dis; 2016 May; 53(2):651-60. PubMed ID: 27232217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith SR; Robertson J; Rowe CC; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Masters CL; Maruff P;
    Arch Clin Neuropsychol; 2019 Jul; 34(5):585-598. PubMed ID: 30272115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.
    Huijbers W; Mormino EC; Schultz AP; Wigman S; Ward AM; Larvie M; Amariglio RE; Marshall GA; Rentz DM; Johnson KA; Sperling RA
    Brain; 2015 Apr; 138(Pt 4):1023-35. PubMed ID: 25678559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
    J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI.
    Harrington KD; Lim YY; Ellis KA; Copolov C; Darby D; Weinborn M; Ames D; Martins RN; Savage G; Szoeke C; Rowe C; Villemagne VL; Masters CL; Maruff P
    Int Psychogeriatr; 2013 Oct; 25(10):1667-77. PubMed ID: 23866942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    White JP; Schembri A; Prenn-Gologranc C; Ondrus M; Katina S; Novak P; Lim YY; Edgar C; Maruff P
    J Alzheimers Dis; 2023; 96(4):1781-1799. PubMed ID: 38007647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
    Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration.
    Guerville F; De Souto Barreto P; Coley N; Andrieu S; Mangin JF; Chupin M; Payoux P; Ousset PJ; Rolland Y; Vellas B;
    J Am Geriatr Soc; 2021 Mar; 69(3):651-659. PubMed ID: 33217785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
    Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
    J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.